These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
255 related items for PubMed ID: 29723483
41. Care-by-parent model as a tool for reduction of neonatal opioid withdrawal syndrome in neonates exposed to buprenorphine maintenance therapy in-utero. Lawlor ML, Shook LA, McQuerry K, Srinivasan A, Johnson QB, Chavan NR, Critchfield AS. J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2718-2722. PubMed ID: 30563376 [Abstract] [Full Text] [Related]
42. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Kakko J, Heilig M, Sarman I. Drug Alcohol Depend; 2008 Jul 01; 96(1-2):69-78. PubMed ID: 18355989 [Abstract] [Full Text] [Related]
43. Delivery dose of methadone, but not buprenorphine, is associated with the risk and severity of neonatal opiate withdrawal syndrome. Lappen JR, Stark S, Bailit JL, Gibson KS. Am J Obstet Gynecol MFM; 2020 Feb 01; 2(1):100075. PubMed ID: 33345989 [Abstract] [Full Text] [Related]
44. Neonatal abstinence syndrome: treatment and pediatric outcomes. Logan BA, Brown MS, Hayes MJ. Clin Obstet Gynecol; 2013 Mar 01; 56(1):186-92. PubMed ID: 23314720 [Abstract] [Full Text] [Related]
48. Evaluation of a Nurse-Led Program for Rural Pregnant Women With Opioid Use Disorder to Improve Maternal-Neonatal Outcomes. Paterno MT, Jablonski L, Klepacki A, Friedmann PD. J Obstet Gynecol Neonatal Nurs; 2019 Sep 01; 48(5):495-506. PubMed ID: 31374181 [Abstract] [Full Text] [Related]
51. Delayed villous maturation in term placentas exposed to opioid maintenance therapy: a retrospective cohort study. Serra AE, Lemon LS, Mokhtari NB, Parks WT, Catov JM, Venkataramanan R, Caritis SN. Am J Obstet Gynecol; 2017 Apr 01; 216(4):418.e1-418.e5. PubMed ID: 28024988 [Abstract] [Full Text] [Related]
52. Buprenorphine and methadone for opioid addiction during pregnancy. Mozurkewich EL, Rayburn WF. Obstet Gynecol Clin North Am; 2014 Jun 01; 41(2):241-53. PubMed ID: 24845488 [Abstract] [Full Text] [Related]
53. ACOG Committee Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy. ACOG Committee on Health Care for Underserved Women, American Society of Addiction Medicine. Obstet Gynecol; 2012 May 01; 119(5):1070-6. PubMed ID: 22525931 [Abstract] [Full Text] [Related]
54. Opioid dependence and pregnancy: minimizing stress on the fetal brain. McCarthy JJ, Leamon MH, Finnegan LP, Fassbender C. Am J Obstet Gynecol; 2017 Mar 01; 216(3):226-231. PubMed ID: 27729254 [Abstract] [Full Text] [Related]
55. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy. Johnson S, Martin PR. Am J Drug Alcohol Abuse; 2018 Mar 01; 44(3):310-316. PubMed ID: 28829626 [Abstract] [Full Text] [Related]
56. Feasibility of collaborative care treatment of opioid use disorders with buprenorphine during pregnancy. Mittal L, Suzuki J. Subst Abus; 2017 Mar 01; 38(3):261-264. PubMed ID: 26672650 [Abstract] [Full Text] [Related]
57. Number of buprenorphine induction attempts impacts maternal and neonatal outcomes: a multicenter cohort study. Kelly JC, Ayala NK, Holroyd L, Raghuraman N, Carter EB, Williams SA, Mills MM, Friedman H, Zhang F, Townsel C. Am J Obstet Gynecol MFM; 2023 Jul 01; 5(7):100998. PubMed ID: 38236700 [Abstract] [Full Text] [Related]
58. The Effect of Sexual Abuse and Prenatal Substance Use on Successful Breastfeeding. Jansson LM, Velez ML, Butz AM. J Obstet Gynecol Neonatal Nurs; 2017 Jul 01; 46(3):480-484. PubMed ID: 28371620 [Abstract] [Full Text] [Related]
59. Breastfeeding initiation among macrosomic infants born to obese nondiabetic mothers. Cordero L, Oza-Frank R, Landon MB, Nankervis CA. Breastfeed Med; 2015 Jun 01; 10(5):239-45. PubMed ID: 25973675 [Abstract] [Full Text] [Related]
60. Treating women with opioid use disorder during pregnancy in Appalachia: Initial neonatal outcomes following buprenorphine + naloxone exposure. Nguyen L, Lander LR, O'Grady KE, Marshalek PJ, Schmidt A, Kelly AK, Jones HE. Am J Addict; 2018 Mar 01; 27(2):92-96. PubMed ID: 29473258 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]